A detailed history of New Millennium Group LLC transactions in Amgen Inc stock. As of the latest transaction made, New Millennium Group LLC holds 12 shares of AMGN stock, worth $3,872. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12
Holding current value
$3,872
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$262.75 - $319.31 $3,153 - $3,831
12 New
12 $3,000
Q4 2023

Jan 17, 2024

BUY
$255.7 - $288.46 $255 - $288
1 Added 9.09%
12 $3,000
Q2 2023

Aug 03, 2023

SELL
$214.27 - $253.37 $1,071 - $1,266
-5 Reduced 31.25%
11 $2,000
Q1 2023

Apr 28, 2023

BUY
$225.79 - $275.2 $225 - $275
1 Added 6.67%
16 $3,000
Q2 2022

Aug 18, 2022

BUY
$230.71 - $256.74 $3,460 - $3,851
15 New
15 $4,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $173B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track New Millennium Group LLC Portfolio

Follow New Millennium Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Millennium Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Millennium Group LLC with notifications on news.